AIM ImmunoTech Revenue, Growth & Competitor Profile

DBA HEMISPHERX BIOPHARMA, INC.

Company Profile & Annual Report for AIM ImmunoTech

Access the complete profile.

AIM ImmunoTech Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	4242 Drugs & Druggists' Sundries Merchant Wholesalers
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	2117 Sw Highway 484 Ocala, FL 32801

Note: Revenues for privately held companies are statistical evaluations.


AIM ImmunoTech's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • AIM ImmunoTech's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • AIM ImmunoTech is classified as operating in the Drugs & Druggists' Sundries Merchant Wholesalers industry, NAICS Code 4242.

AIM ImmunoTech Annual Revenue and Growth Rate

AIM ImmunoTech	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: AIM ImmunoTech's revenues are gauged from an analysis of company filings.

AIM ImmunoTech's Income Statement (based on Industry Averages)

AIM ImmunoTech P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that AIM ImmunoTech is developing and marketing. AIM ImmunoTech doesn't have any recent trademark applications, indicating AIM ImmunoTech is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
AIM Intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of injuries resulting from surgery, thermal accidents or burns; Interferons; Parenterally administered interferon for use in treating viral diseases, immunological disorders and cancer; Pharmaceutical products, namely, pharmaceutical preparations for treatment of viral and infectious diseases, cancer, immune disorders and ME/CFS; intranasal solutions for use as a vaccine adjuvant	02/07/2020
AMPLIFIED IMMUNO MODULATION INC. Intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of injuries resulting from surgery, thermal accidents or burns; Interferons; Parenterally administered interferon for use in treating viral diseases, immunological disorders and cancer; Pharmaceutical products, namely, pharmaceutical preparations for treatment of viral and infectious diseases, cancer, immune disorders and ME/CFS; intranasal solutions for use as a vaccine adjuvant	08/22/2019
HEMISPHERX Intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of injuries resulting from surgery, thermal accidents or burns; Interferons; Parenterally administered interferon for use in treating viral diseases, immunological disorders and cancer; Pharmaceutical products, namely, pharmaceutical preparations for treatment of viral and infectious diseases, cancer, immune disorders and ME/CFS	06/07/2019

See all trademarks and details in the Full Report.

Market Share of AIM ImmunoTech's Largest Competitors

A competitive analysis shows these companies are in the same general field as AIM ImmunoTech, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
AMERISOURCEBERGEN	Conshohocken, PA	100
MCKESSON	Irving, TX	58
CARDINAL HEALTH 119	Dublin, OH	42
TAKEDA PHARMACEUTICALS AMERICA	Lexington, MA	31
CATALENT PHARMA SOLUTIONS	Somerset, NJ	13
OWENS & MINOR DISTRIBUTION	Mechanicsville, VA	11
J M SMITH	Spartanburg, SC	3
DAIICHI SANKYO	Basking Ridge, NJ	3
HIKMA PHARMACEUTICALS USA	Berkeley Heights, NJ	2

Nearby Competitors

These companies are similar in business line and location to AIM ImmunoTech. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
XEC	Orlando, FL	100
JUBILANT DRAXIMAGE RADIOPHARMACIES	Orlando, FL	22
AIM IMMUNOTECH	Ocala, FL	6
PRO SKIN SOLUTIONS	Orlando, FL	2
STAR-LIGHT CREATIONS	Orlando, FL	1

Future Competition: AIM ImmunoTech's Fastest Growing Competitors

These companies are in the same general field as AIM ImmunoTech and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)